Local Coverage Article Response to Comments

Response to Comments: Vitamin D Assay Testing


Expand All | Collapse All

Contractor Information

Article Information

General Information

Article ID
Article Title
Response to Comments: Vitamin D Assay Testing
Article Type
Response to Comments
Original Effective Date
Retirement Date
AMA CPT / ADA CDT / AHA NUBC Copyright Statement

CPT codes, descriptions and other data only are copyright 2022 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

Current Dental Terminology © 2022 American Dental Association. All rights reserved.

Copyright © 2022, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the American Hospital Association (AHA) copyrighted materials contained within this publication may be copied without the express written consent of the AHA. AHA copyrighted materials including the UB‐04 codes and descriptions may not be removed, copied, or utilized within any software, product, service, solution or derivative work without the written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816.

Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only authorized with an express license from the American Hospital Association. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. The views and/or positions presented in the material do not necessarily represent the views of the AHA. CMS and its products and services are not endorsed by the AHA or any of its affiliates.

Article Guidance

Article Text
Noridian's Response to Provider Recommendations for Vitamin D Assay Testing (for comment period ending 08/08/2016).

Response To Comments

1Comments from ACLA (American Clinical Laboratory Association) recommended a number of additional diagnostic codes for testing of Vitamin D, including inflammatory gastrointestinal diseases, certain infections, radiation enteritis, certain lymphomas, selected bone and cartilages conditions, hepatobiliary diseases and others. Noridan will add these codes. Noridian does not feel that bariatric surgery, as a specific entity, should be included because the more recent forms of surgery may not require constant measurements of the vitamin; and if any sign or symptom of malabsorption or enteritis are present, those diagnoses would allow for the testing-as well as post-surgical malabsorption already in the policy.
2The College of American Pathology commented with suggestions of wording changes in the language of the policy. The recommended wording changes: “although it is not the active form of the hormone, 25-OH vitamin D is much more commonly measured because it better reflects the sum total of vitamin D produced endogenously and absorbed from the diet than does the level of the active hormone 1,25-dihydroxy vitamin D. Deficiency of 1,25-dihydroxy vitamin D, which is present at much lower concentrations, does not necessarily reflect deficiency of 25-OH vitamin D and its measurement should be limited to the indications listed.”Wording changes have been added to the policy.
3The Endocrine Society recommends evaluation for patients on anticonvulsants, antiretroviral HIV therapy, glucocorticoids, antifungals, and cholestyramine. Rather than list all the diagnoses or drugs involved.Noridian believes using codes for long term drug use should be simpler and more efficient for both the physician and reviewer.
4Comment from a Contractor Advisory Committee Member: recommendation to add graft versus host disease with associated malnutrition, prolonged steroid therapy with or without treatment of bisphosphonates.Noridian feels the codes for long term drug use will work for long term steroids, and will add graft versus host disease diagnosis.

Associated Documents

Related Local Coverage Documents
Related National Coverage Documents
Public Versions
Updated On Effective Dates Status
12/01/2016 02/03/2017 - N/A Currently in Effect You are here


  • Vitamin D
  • Assay
  • Testing
  • 82306
  • 82652